Trial
NCT04026997
A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
CinDome Pharma, Inc.
Collaborators
—
Condition
Gastroparesis
Intervention
CIN-102 Dose 1
Why stopped
Terminated based on Sponsor decision due to lot recall of GEBT kits impacting the primary endpoint evaluation for Dose 2 and Dose 3.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-25